In this randomized controlled trial, abelacimab led to significantly lower rates of major or clinically relevant nonmajor ...
In this randomized clinical trial, among patients who had an out-of-hospital cardiac arrest, no significant difference was ...
In this randomized trial, intraosseous-first vascular access did not result in higher 30-day survival than intravenous-first ...
In this randomized controlled trial, adjuvant trastuzumab emtansine (T-DM1) reduced invasive disease events in patients with ...
The number of mpox cases in Africa increased leading up to the first mpox declaration of a Public Health Emergency of ...
In this randomized controlled trial, a transcatheter tricuspid-valve replacement provided a mortality benefit compared to ...
In this randomized controlled trial, among patients with persistent chylomicronemia, it was found that plozasiran more ...
In this randomized controlled trial, cabozantinib significantly improved progression-free survival in patients with ...
In this case series, agricultural workers who contracted A(H5N1) experienced mild illnesses of short duration, with no ...
In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...
Vutrisiran treatment reduced the risk of death and recurrent cardiovascular events compared to placebo in patients with ...
1. In this randomized controlled trial, cabozantinib significantly improved progression-free survival in patients with progressive pancreatic and extra-pancreatic neuroendocrine tumors. ...